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Abstract
Background: The glutamate receptors (GluRs) play a vital role in the mediation of excitatory
synaptic transmission in the central nervous system. To clarify the evolutionary dynamics and
mechanisms of the GluR genes in the lineage leading to humans, we determined the complete
sequences of the coding regions and splice sites of 26 chimpanzee GluR genes.
Results: We found that all of the reading frames and splice sites of these genes reported in humans
were completely conserved in chimpanzees, suggesting that there were no gross structural changes
in humans after their divergence from the human-chimpanzee common ancestor. We observed low
KA/KS ratios in both humans and chimpanzees, and we found no evidence of accelerated evolution.
We identified 30 human-specific "fixed" amino acid substitutions in the GluR genes by analyzing 80
human samples of seven different populations worldwide. Grantham's distance analysis showed that
GRIN2C and GRIN3A are the most and the second most diverged GluR genes between humans and
chimpanzees. However, most of the substitutions are non-radical and are not clustered in any
particular region. Protein motif analysis assigned 11 out of these 30 substitutions to functional
regions. Two out of these 11 substitutions, D71G in GRIN3A and R727H in GRIN3B, caused
differences in the functional assignments of these genes between humans and other apes.
Conclusion:  We conclude that the GluR genes did not undergo drastic changes such as
accelerated evolution in the human lineage after the divergence of chimpanzees. However, there
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remains a possibility that two human-specific "fixed" amino acid substitutions, D71G in GRIN3A and
R727H in GRIN3B, are related to human-specific brain function.
Background
Glutamate is the most abundant fast-excitatory neuro-
transmitter in the central nervous system (CNS) and gluta-
mate receptors (GluRs) play a vital role in the mediation
of excitatory synaptic transmission. Because of their roles
in neurotransmission and synaptic plasticity, GluRs are
thought to be key molecules in cognitive functions such as
learning and memory (reviewed in [1-3]). Based on their
structural and functional characteristics, GluRs are classi-
fied into two major groups: ionotropic glutamate recep-
tors (iGluRs) and metabotropic glutamate receptors
(mGluRs) (Reviewed in [3]). Vertebrate iGluRs are phar-
macologically classified into four subgroups by their lig-
and selectivity: NMDA, AMPA, kainate, and delta. While
iGluRs directly regulate the ion flux across the cell mem-
brane as ion channels, mGluRs are involved in a variety of
intracellular signaling pathways by activating phospholi-
pase C and/or suppressing adenlylate cyclase and subse-
quently mediating excitatory neurotransmission and
synaptic plasticity by affecting iGluR activities.
Recent studies have reported that the genetic variations in
GluRs are associated with multiple neurobehavioral phe-
notypes in humans including addictions, anxiety/dyspho-
ria disorders, schizophrenia, and epilepsy [e.g., [4-12]].
These observations suggest that genetic variations in
GluRs cause brain dysfunctions in humans. A study of the
evolutionary genetic changes in the GluR genes would
provide us with insights into the molecular basis of
human-specific brain and nervous system functions.
The evolutionary changes that occurred in the GluR genes
in the lineage leading to humans are poorly understood,
mainly because of the limited availability of relevant
information in public databases. To overcome this prob-
lem, we determined the complete coding sequences of 26
GluR genes in chimpanzees (Pan troglodytes) and con-
ducted a comparative genomic analysis of all GluR genes.
We examined whether positive selection plays a role in the
evolution of the GluR gene family after the divergence of
humans and chimpanzees and investigated human-spe-
cific "fixed" nonsynonymous substitutions in the GluR
genes that might be associated with human-specific brain
function.
Results
We determined the complete nucleotide sequences of the
coding exons for 21 chimpanzee glutamate receptor
(GluR) genes: GRIA3, GRIA4, GRID1, GRID2, GRIK1,
GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2C,
GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM4,
GRM6, GRM7, and GRM8. The sequences of five addi-
tional chimpanzee GluR genes, GRIA1, GRIA2, GRIN2B,
GRM3, and GRM5 were obtained from the UCSC Genome
Database (version panTro1) [13]. Successful alignments
of the entire coding regions and splice sites of the human
and chimpanzee GluR genes indicated no gross structural
differences such as protein truncation between humans
and chimpanzees.
The pairwise nucleotide divergence
We calculated the pairwise nucleotide divergence in total
and synonymous sites between humans and chimpanzees
for all of the genes encoding NMDA, AMPA, kainate,
delta, and metabotropic glutamate receptors (Table 1).
The divergence for the entire set of GluR genes both at
total and synonymous sites was 0.00461 and 0.01257,
respectively, which is significantly lower than the
genome-wide average values, which are 0.0059 and
0.0177 (more than 2 SD below the mean in a normal dis-
tribution, [14]). Indeed, except for the NMDA type, the
divergence for each type was significantly lower than the
genome-wide average at total and synonymous sites
(more than 2 SD below the mean).
The AMPA type genes showed the lowest divergence of the
GluR types at both total and synonymous sites (0.00242
± 0.00053 and 0.00792 ± 0.00167 at total and synony-
mous sites, respectively). The divergence of the four indi-
vidual AMPA genes ranged from 0.00075 to 0.00303 at
total sites and from 0.00056 to 0.00103 at synonymous
sites. Therefore, the AMPA type genes showed lower diver-
gence than the other GluR types. The divergence for the
NMDA type genes was the highest of all of the GluR types
at both total and synonymous sites (0.00594 ± 0.00045
and 0.01477 ± 0.00141). This observed higher divergence
Table 1: The pairwise nucleotide divergence per site at total and 
synonymous sites between humans and chimpanzees
Type Total sites Synonymous sites
AMPA 0.00242 ± 0.00053 0.00792 ± 0.00167
Delta 0.00432 ± 0.00076 0.01341 ± 0.00292
Kainate 0.00429 ± 0.00047 0.01288 ± 0.00166
NMDA 0.00594 ± 0.00045 0.01477 ± 0.00141
mGluR 0.00444 ± 0.00041 0.01186 ± 0.00122
All GluRs 0.00461 ± 0.00019 0.01257 ± 0.00056BMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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can be attributed to two NMDA type GluR genes, GRIN3A
and  GRIN3B. The GRIN3B  and  GRIN3A  genes are the
most and the second most diverged GluR genes between
humans and chimpanzees at both types of site (0.01351
and 0.00965 at total sites and 0.03023 and 0.02844 at
synonymous sites). When we excluded GRIN3A  and
GRIN3B from this analysis, the NMDA type genes were
found to have similar divergences to the other gene types
at total and synonymous sites (0.00425 ± 0.00040 and
0.01154 ± 0.00135).
Lineage-specific KA/KS ratios and selection tests
Intrigued by the possible functional implications of the
GluR genes in the evolutionary process of the human lin-
eage, we examined whether positive selection acted on the
GluR genes in humans and chimpanzees. At first, using
macaque sequences as an outgroup, we calculated the
human and chimpanzee lineage-specific nonsynonymous
and synonymous substitution rates (KA and KS, respec-
tively) and their ratios (KA/KS, Table 2). Notably, the KA/
KS ratios for the GluR genes were less than one in both the
human and chimpanzee lineages, although we could not
calculate the ratios for 11 human and 11 chimpanzee
GluR genes due to the absence of nonsynonymous substi-
tutions. Excluding the genes with no substitutions, the KA/
KS ratios ranged from 0.0004 to 0.417 and 0.0005 to
0.242 in human and chimpanzee lineages, respectively.
The KA/KS ratios for 24 human GluR genes and all of the
chimpanzee GluR genes are smaller than the species-spe-
cific genome-wide mean values (0.259 and 0.245 in
human and chimpanzee, respectively [15]). These results
indicate that the functional constraint on the GluR is rel-
atively strong.
Two maximum likelihood ratio tests (implemented in
PAML [16]) were employed to examine the KA/KS for the
GluR genes in the human lineage and to evaluate the
accelerated selection for the GluR genes in humans and
chimpanzees. First, we compared the KA/KS ratios in the
human lineage vs. background (chimpanzee and
macaque) lineages. We observed that the human-specific
KA/KS ratio is significantly different from the background
ratio in GRM7 according to test B outlined in [17] (Addi-
tional file 1). Taking the KA/KS value into account, this
result implies that the human KA/KS ratio is significantly
lower than that of the background in GRM7. We then
applied the improved branch-site model [18] to examine
whether positive selection acted on the GluR genes in
humans and chimpanzees, but could not detect any sig-
nificant accelerated selection in either human or chim-
panzee lineages (Additional file 2).
Identification of human-specific "fixed" nonsynonymous 
mutations
To evaluate the functional changes of the GluR genes in
the human lineage, we searched for human-specific
"fixed" nonsynonymous substitutions. First, we carried
out a pairwise comparison between the human and chim-
panzee orthologs of 26 GluR genes. We found a total of 80
nonsynonymous substitutions including four indels
(insertion/deletion) (Table 3). Out of the 80 substitu-
tions, two substitutions were excluded from further anal-
ysis due to discrepancies among the UCSC reference and
our chimpanzee sequences; these two substitutions are
possibly polymorphic within chimpanzees. Second, we
sequenced the remaining 78 substitution/indel sites in
five additional apes: the bonobo, gorilla, orangutan, sia-
mang, and crab-eating macaque. We regarded human alle-
les that were not shared with any of the great apes to be
"human-specific". We pooled substitutions that were
found specifically either in chimpanzees or in bonobos as
"chimpanzee-specific" substitutions, because these muta-
tions must have occurred in the chimpanzee and bonobo
lineages after the divergence of the human lineage. Out of
the 78 human-chimpanzee substitution sites, we identi-
fied 37 human-specific (35 substitutions and 2 indels)
and 31 chimpanzee-specific substitutions/indels (29 sub-
Table 2: The nonsynonymous and synonymous rates and their 
ratio in the human and chimpanzee lineages
Human Chimpanzee
gene KA KS KA/KS KA KS KA/KS
GRIA1 00 . 0 0 5 10 00 . 0 0 5 30
GRIA2 00 . 0 0 4 10 00 . 0 0 6 90
GRIA3 00 . 0 0 1 200 . 0 0 0 50 0
GRIA4 0.0006 0.0059 0.0933 0 0.0023 0
GRID1 0.0009 0.0093 0.0947 0 0.007 0
GRID2 00 . 0 1 0 900 . 0 0 0 5 0 .0032 0.1495
GRIK1 00 . 0 0 2 40 00 . 0 1 0 60
GRIK2 00 . 0 0 2 80 00 . 0 0 4 30
GRIK3 0.0005 0.0189 0.0247 0.0005 0.0197 0.0236
GRIK4 0.0004 0.0139 0.0323 0 0.0064 0
GRIK5 0.0013 0.0055 0.2313 0.0004 0.0041 0.1025
GRIN1 00 . 0 1 5 90 00 . 0 0 5 10
GRIN2A 0.0009 0.0066 0.1396 0.0009 0.0075 0.1244
GRIN2B 00 . 0 0 7 800 . 0 0 0 3 0 .0058 0.0518
GRIN2C 0.0023 0.013 0.1745 0.0015 0.0129 0.1157
GRIN2D 0 0.013 0 0 0.005 0
GRIN3A 0.0026 0.0087 0.2976 0.0017 0.015 0.1131
GRIN3B 0.0017 0.0447 0.0388 0 0 0
GRM1 0.0004 0.0082 0.0466 0.0004 0.0042 0.0901
GRM2 0.0005 0.0108 0.049 0.0005 0.0074 0.0709
GRM3 0.0005 0.0013 0.417 0.0011 0.0044 0.2422
GRM4 00 . 0 1 0 900 . 0 0 0 5 0 .0069 0.0663
GRM5 00 . 0 0 3 10 00 . 0 0 5 70
GRM6 0.0025 0.0224 0.1123 0.0016 0.0159 0.1038
GRM7 0.0005 0.0105 0.0514 0.0011 0.0071 0.1521
GRM8 0.0005 0.0039 0.1327 0.001 0.0055 0.1902
KA, KS, and KA/KS indicate nonsynonymous, synonymous, and the 
nonsynonymous/synonymous substitution rate (per site), respectively.BMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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Table 3: Comparison of human-chimpanzee substitutions among primates






Hum Chimp Bon Gor Ora Gib Mac #1 Mac #2 Specificity1 Fixed in 
Humans
Notes
1 GRIN2A S906N AGC-AAC G A A A A A A A Human Fixed
2 GRIN2A A1006V GCG-GTG C T T T T T T T Human Fixed
3 GRIN2A H1080P CAC-CCC A C A A A A A A Chimpanzee
4 GRIN2A F1158L TTC-TTG G CC G G G G G Chimpanzee
5 GRIN2A H1173Q CAT-CAA A TT A A A A A Chimpanzee
6 GRIN2A M1221L ATG-CTG A C C C C C C C Human Fixed
7 GRIN2B N1294T AAC-ACC A CC A A A A A Chimpanzee
8 GRIN2C P23L CCG-CTG CCG ATG CTG CCG CTG CGG CCG CCG N.A.
9 GRIN2C T71N ACC-AAC C AA A CC AA N . A .
10 GRIN2C H89R CAC-CGC A G G G G G G G Human Fixed
11 GRIN2C D100G GAC-GGC A G G G G G G G Human Fixed
12 GRIN2C A596S GCT-TCT G T T T "T" T T T Human Fixed
13 GRIN2C S851T TCC-ACC T AA T T T T T Chimpanzee
14 GRIN2C Q898R CAG-CGG A A/G - A A A A A Chimpanzee
15 GRIN2C S933P TCC-CCC T C - - C C "C" "C" Human Fixed
16 GRIN2C G1144S GGC-AGC G AA G* G G "G" "G" Chimpanzee *AGG
17 GRIN2C R1221C CGT-TGT C T T - "T" T "T" "T" Human Fixed
18 GRIN3A S30G AGC-GGC A G G - "G" G G G Human Fixed
19 GRIN3A D71G GAC-GGC A G G - "G" G G G Human Fixed
20 GRIN3A P93L CCG-CTG C TT C C C C* C* Chimpanzee *TCG
21 GRIN3A A119T GCG-ACG G A G G G G G G Chimpanzee
22 GRIN3A A121T GCC-ACC G A A A A A A A Human Fixed
23 GRIN3A V138M GTG-ATG G A G G G* G* G* G Chimpanzee *GGG
24 GRIN3A E340K GAA-AAA G A G G G G G G Chimpanzee
25 GRIN3A A885S GCC-TCC G T T T T T T T Human Fixed
26 GRIN3A I988V ATA-GTA A G G G G G G G Human Fixed
27 GRIN3A R1059L CGG-CTG G T T - T T T T Human Fixed
28 GRIN3B P17S CCG-TCG C TT C C C C C Chimpanzee
29 GRIN3B G175S GGC-AGC G A G - G G G G Chimpanzee
30 GRIN3B E229G GAA-GGA A G A - A A - A Chimpanzee
31 GRIN3B A272V GCG-GTG C T C C C* C C* C* Chimpanzee *GCA
32 GRIN3B I296T ATT-ACT T CC C * C C * C/T** C* N.A. *ACG,
**ATT/
CCT
33 GRIN3B W414R TGG-CGG T C C C C C C C Human NOT rs2240157
34 GRIN3B A468V GCG-GTG C T T T T T T T Human Fixed
35 GRIN3B R473C CGC-TGC C TT C C C C C Chimpanzee
36 GRIN3B L499I CTC-ATC C A A A A A A A Human Fixed
37 GRIN3B T577M ACG-ATG C T T T T - T T Human NOT rs2240158
38 GRIN3B Y595C TAC-TGC A GG G A- A A N . A .
39 GRIN3B R598C CGT-TGC CGT TGC TGC TGC CGC - CGC CGC N.A.
40 GRIN3B V613I GTC-ATC G A G G G - G G Chimpanzee
41 GRIN3B R727H CGC-CAC G A A A A A "A" "A" Human Fixed
42 GRIA3 P590L CCT-CTT C T C C C C C C Chimpanzee
43 GRIA4 S5C TCC-TGC C G G G G G G G Human Fixed
44 GRIK3 S310A TCC-GCC T G G G "G" G G G Human NOT rs6691840
45 GRIK3 V419I GTT-ATT G AA G G G G G Chimpanzee
46 GRIK4 H403R CAC-CGC A GG G A GG G N . A .
47 GRIK5 L298P CTG-CCG T C C C C C C C Human Fixed
48 GRIK5 I809V ATC-GTC A G G G "G" - G G Human Fixed *GTT
49 GRIK5 A922T GCC-ACC G A - - G G G G Chimpanzee
50 GRIK5 V956A GTC-GCC T C C/T - C/T -C C N . A .BMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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stitutions and 2 indels). The remaining 10 are recurrent
substitutions in the primate lineages. To determine
whether these substitutions/indels are "fixed" or "poly-
morphic" in human populations, we sequenced 80
human samples representing seven different populations
around the world for the 37 human-specific substitution/
indel sites. Table 3 shows the 30 "fixed" (28 substitutions
and 2 indels) and 7 "polymorphic" substitutions/indels
that we confirmed in the human populations. The 30
human-specific "fixed" substitutions are potentially
responsible for human-specific functions.
Functional implications of human-specific "fixed" 
nonsynonymous substitutions
To evaluate the functional significance of each amino acid
substitution in the GluR genes, we calculated Grantham's
distance [19], a measurement of the chemical drasticity of
amino acid replacements. We examined the differences in
amino acid substitution patterns between humans and
chimpanzees using 35 human-specific and 29 chimpan-
zee-specific substitutions after excluding 4 indel sites. We
classified amino acid substitutions into two groups: sub-
stitutions with Grantham's distances greater than 100 (the
51 GRID1 T295M ACG-ATG C T T T T - T T Human Fixed
52 GRID1 M628V ATG-GTG A G G G G G G G Human Fixed
53 GRID2 S11F TCC-TTC C TT C C C C C Chimpanzee
54 GRM1 S993P TCC-CCC T C C C C C C C Human NOT rs6923492
55 GRM1 L1089P CTG-CCG T CC C C CTT N.A. *CCA
56 GRM2 A6G GCG-GGG G C C C C C C C Human Fixed
57 GRM2 A248V GCG-GTG C TT C C C C C Chimpanzee
58 GRM3 M547V ATG-GTG A GG A A A A A Chimpanzee
59 GRM3 S551P TCT-CCT T CC C C CC C H u m a nN O T N o  r s #  
available
60 GRM3 M593T ATG-ACG T C/T T T T T T T Chimpanzee
61 GRM4 L19F CTC-TTC C TT C C C C C Chimpanzee
62 GRM6 Q59P CAG-CCG A C C C C C C C Human NOT rs2645329
63 GRM6 P141T CCC-ACC C A* A A A A A - Human NOT No rs # 
available
*AT/CC
64 GRM6 D380E GAT-GAG T GG T T T T T Chimpanzee
65 GRM6 M442T ATG-ACG T CC C C T CC N . A .
66 GRM6 Y612H TAC-CAC T C C C C C C C Human Fixed
67 GRM6 A650G GCG-GGG C G G C C C T T N.A.
68 GRM6 M714V ATG-GTG A G G G* G G G G Human Fixed *GCG
69 GRM6 V839I GTA-ATA G AA G G G G G Chimpanzee
70 GRM6 A877D GCC-GAC C A A A A A A A Human Fixed
71 GRM7 A520P GCC-CCC C G G G G G G G Human Fixed
72 GRM8 R268C CGC-TGC A G A A A A A A Chimpanzee
73 GRM8 G327V GGG-GTG G G/T G/T G G G G G Chimpanzee






del in in - in in in in Human Fixed




in in/del in - "in" in in in Chimpanzee
77 GRIN2C AH1164-
1165del
GCCCAC in in/del in in in in in - Chimpanzee
78 GRM6 GD125-
126del
GCGACG in del del - del del del - Human Fixed
Abbreviations are: Hum - human, Chimp - chimpanzee, Bon - bonobo, Gor - gorilla, Ora - orangutan, Gib - gibbon, in - insertion, del -- deletion, rs -- RefSNP accession ID.1: 
This shows the lineage in which the substitution (insertion/deletion) occurred. In cases in which the substitution independently occurred at the same site in more than two 
lineages, the specificity is not assigned (N.A.). We pooled substitutions found specifically in chimpanzees or in bonobos as "chimpanzee-specific" substitutions.
" ": The sequence was obtained from the UCSC genome database.
-: We failed to determine the sequence of the site, and the sequence was not available from the UCSC genome database.
*: The other substitution was found in the codon.
Table 3: Comparison of human-chimpanzee substitutions among primates (Continued)BMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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mean chemical distance from the three-property formula
[19]) were classified as "radical" changes and substitu-
tions with Grantham's distance less than 100 were classi-
fied as "non-radical" changes. We found four radical and
30 non-radical changes in the human lineage and four
radical and 25 non-radical changes in the chimpanzee lin-
eage, indicating that there are no significant differences in
the amino acid substitution patterns between humans
and chimpanzees (p = 1 in Fisher's exact test, 2 × 2, two-
tailed). We then summarized Grantham's distance for
each GluR gene that contained one of the 28 human-spe-
cific "fixed" substitutions (Table 4). Among the 11 GluR
genes that have human-specific "fixed" substitutions,
Grantham's distance analysis showed that GRIN2C and
GRIN3A  are the most diverged in humans from the
human-chimpanzee ancestor sequence (476 in GRIN2C
and 438 in GRIN3A). Four out of the five "fixed" substitu-
tions in GRIN2C and five out of the six "fixed" substitu-
tions in GRIN3A are non-radical changes with Grantham's
distances of less than 100. These substitutions are not
located in any particular region, but instead are distrib-
uted throughout the entire gene regions (Table 4). These
results imply that it is unlikely that the accumulation of
non-radical substitutions in GRIN2C and GRIN3A caused
their functional divergence from their ancestors.
Using the MEMSAT3 [20] and MyHits [21], we annotated
the transmembrane and protein motif domains around
the 30 "fixed" human-specific substitution/indel sites
(Table 5). We found that ten substitutions are located
within either transmembrane or protein motif domains:
four in transmembrane domain sites, two in N-glycosyla-
tion sites, two in N-myristoylation sites, and two in phos-
phorylation sites. Out of these ten substitutions, there are
two human-specific and "fixed" substitutions, D71H in
GRIN3A and R27H in GRIN3B, which alter the functional
assignments of their respective genes as determined by the
aforementioned annotation software. D71G in GRIN3A
Table 4: Grantham's distance for GluR genes using human-specific "fixed" amino acid substitutions
Gene Number of substitutions Total Grantham's distance Substitutions
(Amino acid position, Grantham's distance)
GRIN2C 5 476 (89, 29) (100, 94) (596, 99) (933, 74) (1221, 180)
GRIN3A 6 438 (30, 56) (71, 94) (121, 58) (885, 99) (988, 29) (1059, 102)
GRM6 3 230 (612, 83) (714, 21) (877, 126)
GRIK5 2 127 (298, 98) (809, 29)
GRIN2A 3 125 (906, 46) (1006, 64) (1221, 15)
GRIA4 1 112 (5, 112)
GRID1 2 102 (295, 81) (628, 21)
GRIN3B 3 98 (468, 64) (499, 5) (727, 29)
GRM2 1 60 (6, 60)
GRM8 1 29 (653, 29)
GRM7 1 27 (520, 27)
Total 28 1824






GRIN2A S906N AGC-AAC N-glycosylation site
GRIN3A S30G AGC-GGC N-myristoylation site
GRIN3A D71G GAC-GGC N-myristoylation site (lost in humans)
GRIN3A I988V ATA-GTA Casein kinase II phosphorylation site.
GRIN3B A468V GCG-GTG N-glycosylation site
GRIN3B R727H CGC-CAC Protein kinase C phosphorylation site (acquired in humans)
GRIK5 I809V ATC-GTC Transmembrane
GRM2 A6G GCG-GGG N-myristoylation site
GRM6 Y612H TAC-CAC Transmembrane
GRM6 M714V ATG-GTG Transmembrane
GRM8 V653I GTC-ATC TransmembraneBMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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abolishes an N-myristoylation site that is conserved in
other apes and R727H in GRIN3B generates a novel phos-
phorylation site for protein kinase C in the human line-
age. These substitutions may cause functional changes in
human GluRs that contribute to human brain function.
Discussion
In this study, we examined the evolutionary changes of
the glutamate receptor (GluR) genes in humans and chim-
panzees. We found no gross differences in the coding
regions or splice sites of the GluR genes between humans
and chimpanzees. We also demonstrated that the average
rate of protein evolution (i.e. the KA/KS ratio) is signifi-
cantly lower in the GluR genes than the genome-wide
average values for humans and chimpanzees. This pattern
is consistent with previous genome-wide studies
[15,22,23], indicating that strong purifying selection acts
on brain-expressed genes including the GluR genes due to
their strict functional constraint. There are no significant
differences between humans and chimpanzees with
regard to their KA/KS values (Table 2) or substitution pat-
terns (Table 4). These results imply that no gross func-
tional changes occurred in either lineage after the human-
chimpanzee divergence.
Dorus et al. [24] found an increase in the KA/KS ratio of
genes involved in the nervous system of primates relative
to rodents when housekeeping genes are treated as a con-
trol, leading to the conclusion that the primate nervous
system genes have experienced accelerated evolution. Our
results indicate similar KA/KS ratios between these primate
nervous system genes and the GluR genes. Although our
KA/KS ratio values for the GluR genes are higher than those
of housekeeping genes as discussed in Dorus et al. [24], we
conclude that the GluR genes have been subject to strong
functional constraint rather than rapid positive selection
detected as accelerated evolution for the following rea-
sons: First, we could not detect any positive selection for
the GluR genes using the statistical tests reported by Dorus
et al. [24]. Although the statistical power of the tests may
have been somewhat affected by the scarcity of substitu-
tions, the improved branch-site test can detect single
amino acid substitutions positively selected [18]. Second,
there is no local accumulation of amino acid substitutions
that could have caused the functional divergence of
domains in the GluR genes. Grantham's distance analyses
showed that GRIN2C and GRIN3A are the most and the
second most diverged GluR genes between humans and
chimpanzees. However, most of the substitutions in these
genes are non-radical and are not clustered in any partic-
ular region. Third, we identified only two out of the 28
human-specific "fixed" substitutions in the assigned func-
tional transmembrane region. This observation strongly
supports severe functional constraint acting on the coding
regions of the GluR genes, especially on the functionally
important domains.
Niemann et al. [25] reported a common null allele of
GRIN3B with no particular phenotype, indicating relaxed
functional constraints on GRIN3B in the human lineage.
However, we observed a low KA/KS ratio (0.2976) and a
low Grantham's distance (98) for human GRIN3B. Gene
loss or decay might still contribute to functional changes
by modifying the genetic network. In fact, NR3B knockout
mice have been reported to show highly increased social
interaction with their cage mates in their home cage but
moderately increased anxiety-like behavior and decreased
social interaction in a novel environment [26]. The pres-
ence of NR3 in NMDA receptors has been shown to
decrease Mg+2 sensitivity and Ca+2 permeability, reduce
agonist-induced current responses, and give rise to a new
class of excitatory glycine receptors [27]. These observa-
tions suggest that NR3 has a significant role in higher
brain functions through tetrameric formation with other
NR subunits. Two out of the 28 human-specific "fixed"
substitutions, D71G in GRIN3A and R727H in GRIN3B,
changed the functional assignments between humans and
other apes, causing the loss of a myristoylation site and
the gain of a phosphorylation site, respectively. Since myr-
istoylation and phosphorylation are commonly involved
in processes related to synaptic plasticity including long-
term potentiation and long-term depression in glutamate
receptors [28], these two substitutions possibly affect
human-specific brain function by modulating NMDA
receptor characteristics.
Conclusion
The results of our comparative genetic study enable us to
speculate about the evolutionary changes affecting
human-specific brain function that occurred in the GluR
genes. We showed that strong purifying selection is the
major evolutionary force in the GluR genes shared by
humans and chimpanzees. We identified 30 human-spe-
cific "fixed" amino acid substitutions/indels including
two amino acid substitutions that potentially alter the
functional roles of their genes as candidate sites responsi-
ble for human-specific brain function. Our results are val-
uable for understanding the molecular basis of the brain
and nervous system in humans and help us to clarify
human GluR functions in in vitro and in vivo experiments.
Methods
Sequence data for human, chimpanzee and macaque
Using the longest isoform transcript as a reference (Addi-
tional file 3), we retrieved the coding sequences of 26
glutamate receptor (GluR) human and chimpanzee genes
from the UCSC Genome Browser (hg18 and panTro2 for
humans and chimpanzees, respectively)[12]. Since onlyBMC Evolutionary Biology 2009, 9:224 http://www.biomedcentral.com/1471-2148/9/224
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partial genomic sequences were available for 21 chimpan-
zee genes, we determined the chimpanzee sequence for
the 21 genes using either PCR-based direct sequencing or
a BAC-based cloning-sequencing method (Additional file
3). These genomic GluR sequences were deposited in Gen-
Bank (accession numbers: AB514205-AB514225). The
genomic sequences of macaque homologs were also
obtained from the UCSC Genome Browser (rheMac2).
DNA samples
Primate DNA samples were kindly provided by Dr.
Osamu Takenaka of the Primate Research Institute at
Kyoto University and Dr. Takafumi Ishida from the
Department of Biological Sciences at the Graduate School
of Science of The University of Tokyo. Japanese samples
and Thai samples were collected from the Kyushu area of
Japan and the Chiang Mai area of Thailand with written
informed consent. Other ethnic human samples were pur-
chased from The Coriell Institute for Medical Research
[29]. We identified human-specific substitution sites by
determining the sequences of five primate species, the
bonobo (Pan paniscus) gorilla (Gorilla gorilla ssp), orangu-
tan (Pongo pygmaeus pygmaeus), Siamang (Symphalangus
syndactylus), crab-eating macaque (Macaca fascicularis),
and green monkey (Chlorocebus aethiops) at the human-
chimpanzee substitution sites. Then, we analyzed 80
human DNA samples (Additional file 4), including 7 pop-
ulations, to confirm "fixation" of these mutations in
human species. This study was approved by the Ethics
Committee of the Faculty of Medicine at Kyushu Univer-
sity.
PCR amplification and sequencing
The PCR primers were designed based on the alignments
of human and chimpanzee GluR genes using Primer3
[30]. PCR amplification was carried out using 10 μl sam-
ples containing 1 μg of genomic DNA, PCR buffer, 2.5
mM dNTPs (Promega, Madison, WI), 0.7 units Taq DNA
polymerase (Promega, Madison, WI), 25 mM MgCl2, and
10 μM forward and reverse primers. Primer pairs and PCR
conditions are described in Additional file 5. After the
PCR reaction, we treated the reaction mixtures with 1 U of
Exonuclease I (New England Biolabs) and 0.1 U of SAP
(Shrimp Alkaline Phosphatase; Roche Applied Science,
Indianapolis, IN) to remove the primers.
All sequencing reactions were performed using 10 μl sam-
ples containing 1 μl of PCR product, 1.6 μM sequencing
primer, and 0.25 μl of BigDye Terminator v1.1 or v.3.1
(Applied Biosystems, Foster City, CA). The conditions for
the sequencing reaction were 96°C for 90 seconds, 50°C
for 5 seconds, and 60°C for 60 seconds for 25 cycles. The
sequencing products were purified by ethanol precipita-
tion and then analyzed on an ABI 3100 or 3730 (Applied
Biosystems). Mutation Surveyor v2.2 (SoftGenetics, LLC)
was used to compile the electropherograms.
Data analysis
The pairwise nucleotide divergence was estimated by
MEGA [31]. The Tamura and Nei model [32] and Jukes
and Cantor model [33] were used for total and synony-
mous sites, respectively. Standard errors were computed
by the bootstrap method (1000 replicates). The nonsyn-
onymous and synonymous lineage-specific rates (KA and
KS, respectively) were estimated by the modified Nei and
Gojobori [34] and ML [35] methods as implemented in
the codeml module of PAML [16].
The Grantham's distances for each substitution were
obtained from Table in [19]. Since this distance method is
only applicable to amino acid substitutions, we excluded
insertion/deletion (indel) sites from this analysis. We
used the mean chemical distance from the three-property
formula [19], 100, for the cutoff value of two classes, rad-
ical and non-radical substitution.
Using PAML software, the likelihood ratio test was
applied to examine the following two hypotheses: (1) the
KA/KS ratio was significantly higher in the branch of inter-
est than in the background branch (tests B and D in [17])
and (2) positive selection acted on the branch of interest
(improved branch site model; test 2 in [18]). The tests
were carried out by comparing the log-likelihood values
between the null and alternate hypotheses. Bonferroni
correction was applied to correct for multiple compari-
sons.
The topology of transmembrane domains was predicted
by the MEMSAT3 module [20] of The PSIPRED Protein
Structure Prediction Server [36]. MyHits [21] with the
PROSITE database [37] was used to scan all known pro-
tein motifs.
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